These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 15932816)

  • 1. Relationship between release of platelet/endothelial biomarkers and plasma levels of sertraline and N-desmethylsertraline in acute coronary syndrome patients receiving SSRI treatment for depression.
    Serebruany VL; Suckow RF; Cooper TB; O'Connor CM; Malinin AI; Krishnan KR; van Zyl LT; Lekht V; Glassman AH;
    Am J Psychiatry; 2005 Jun; 162(6):1165-70. PubMed ID: 15932816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet/endothelial biomarkers in depressed patients treated with the selective serotonin reuptake inhibitor sertraline after acute coronary events: the Sertraline AntiDepressant Heart Attack Randomized Trial (SADHART) Platelet Substudy.
    Serebruany VL; Glassman AH; Malinin AI; Nemeroff CB; Musselman DL; van Zyl LT; Finkel MS; Krishnan KR; Gaffney M; Harrison W; Califf RM; O'Connor CM;
    Circulation; 2003 Aug; 108(8):939-44. PubMed ID: 12912814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet inhibition by sertraline and N-desmethylsertraline: a possible missing link between depression, coronary events, and mortality benefits of selective serotonin reuptake inhibitors.
    Serebruany VL; Gurbel PA; O'Connor CM
    Pharmacol Res; 2001 May; 43(5):453-62. PubMed ID: 11394937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet and endothelial activity in comorbid major depression and coronary artery disease patients treated with citalopram: the Canadian Cardiac Randomized Evaluation of Antidepressant and Psychotherapy Efficacy Trial (CREATE) biomarker sub-study.
    van Zyl LT; Lespérance F; Frasure-Smith N; Malinin AI; Atar D; Laliberté MA; Serebruany VL
    J Thromb Thrombolysis; 2009 Jan; 27(1):48-56. PubMed ID: 18188512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of platelet function with depression and its treatment with sertraline in patients with chronic kidney disease: analysis of a randomized trial.
    Jain N; Wan F; Kothari M; Adelodun A; Ware J; Sarode R; Hedayati SS
    BMC Nephrol; 2019 Oct; 20(1):395. PubMed ID: 31664940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maternal sertraline treatment and serotonin transport in breast-feeding mother-infant pairs.
    Epperson N; Czarkowski KA; Ward-O'Brien D; Weiss E; Gueorguieva R; Jatlow P; Anderson GM
    Am J Psychiatry; 2001 Oct; 158(10):1631-7. PubMed ID: 11578995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced platelet/endothelial activation in depressed patients with acute coronary syndromes: evidence from recent clinical trials.
    Serebruany VL; Glassman AH; Malinin AI; Sane DC; Finkel MS; Krishnan RR; Atar D; Lekht V; O'Connor CM
    Blood Coagul Fibrinolysis; 2003 Sep; 14(6):563-7. PubMed ID: 12960610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum disposition of sertraline, N-desmethylsertraline and paroxetine: a pharmacokinetic evaluation of repeated drug concentration measurements during 6 months of treatment for major depression.
    Reis M; Aberg-Wistedt A; Agren H; Höglund P; Akerblad AC; Bengtsson F
    Hum Psychopharmacol; 2004 Jul; 19(5):283-91. PubMed ID: 15252820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HPLC analysis of the second-generation antidepressant sertraline and its main metabolite N-desmethylsertraline in human plasma.
    Mandrioli R; Saracino MA; Ferrari S; Berardi D; Kenndler E; Raggi MA
    J Chromatogr B Analyt Technol Biomed Life Sci; 2006 May; 836(1-2):116-9. PubMed ID: 16581317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The pharmacokinetics of sertraline excretion into human breast milk: determinants of infant serum concentrations.
    Stowe ZN; Hostetter AL; Owens MJ; Ritchie JC; Sternberg K; Cohen LS; Nemeroff CB
    J Clin Psychiatry; 2003 Jan; 64(1):73-80. PubMed ID: 12590627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Depression, coronary events, platelet inhibition, and serotonin reuptake inhibitors.
    Nair GV; Gurbel PA; O'Connor CM; Gattis WA; Murugesan SR; Serebruany VL
    Am J Cardiol; 1999 Aug; 84(3):321-3, A8. PubMed ID: 10496443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of selective serotonin reuptake inhibitor therapy on endothelial function and inflammatory markers in patients with coronary heart disease.
    Pizzi C; Mancini S; Angeloni L; Fontana F; Manzoli L; Costa GM
    Clin Pharmacol Ther; 2009 Nov; 86(5):527-32. PubMed ID: 19641491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Compliance with SSRI medication during 6 months of treatment for major depression: an evaluation by determination of repeated serum drug concentrations.
    Reis M; Aberg-Wistedt A; Agren H; Akerblad AC; Bengtsson F
    J Affect Disord; 2004 Nov; 82(3):443-6. PubMed ID: 15555696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet activation in depression and effects of sertraline treatment: An open-label study.
    Markovitz JH; Shuster JL; Chitwood WS; May RS; Tolbert LC
    Am J Psychiatry; 2000 Jun; 157(6):1006-8. PubMed ID: 10831484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective serotonin re-uptake inhibitors decrease the cytokine-induced endothelial adhesion molecule expression, the endothelial adhesiveness to monocytes and the circulating levels of vascular adhesion molecules.
    Lekakis J; Ikonomidis I; Papoutsi Z; Moutsatsou P; Nikolaou M; Parissis J; Kremastinos DT
    Int J Cardiol; 2010 Mar; 139(2):150-8. PubMed ID: 19004511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sertraline and breastfeeding: review and meta-analysis.
    Pinheiro E; Bogen DL; Hoxha D; Ciolino JD; Wisner KL
    Arch Womens Ment Health; 2015 Apr; 18(2):139-146. PubMed ID: 25589155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of tenecteplase versus alteplase on platelets during the first 3 hours of treatment for acute myocardial infarction: the Assessment of the Safety and Efficacy of a New Thrombolytic Agent (ASSENT-2) platelet substudy.
    Serebruany VL; Malinin AI; Callahan KP; Binbrek A; Van De Werf F; Alexander JH; Granger CB; Gurbel PA;
    Am Heart J; 2003 Apr; 145(4):636-42. PubMed ID: 12679759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sertraline causes strong coronary vasodilation: possible relevance for cardioprotection by selective serotonin reuptake inhibitors.
    van Melle JP; Buikema H; van den Berg MP; van Buiten A; van Veldhuisen DJ; Boonstra PW; van Gilst WH
    Cardiovasc Drugs Ther; 2004 Nov; 18(6):441-7. PubMed ID: 15770431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sertraline and desmethylsertraline in human breast milk and nursing infants.
    Stowe ZN; Owens MJ; Landry JC; Kilts CD; Ely T; Llewellyn A; Nemeroff CB
    Am J Psychiatry; 1997 Sep; 154(9):1255-60. PubMed ID: 9286185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective thromboxane inhibition after vascular protectant AGI-1067: results of assessment of lipoprotein profiles (ALPS) biomarkers in vitro and in vivo substudy.
    Serebruany V; Malinin A; Qiu FH; Xu XC; Kunsch C; Scott R;
    J Thromb Thrombolysis; 2009 May; 27(4):438-46. PubMed ID: 18521540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.